Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence

NCT01535937 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT01535937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01535937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 1/2
Overall status
Terminated
Start date
February 29, 2012
Completion date
April 30, 2017
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine dependence